TY - JOUR
T1 - Evaluating the Machine Learning Literature
T2 - A Primer and User’s Guide for Psychiatrists
AU - Grzenda, Adrienne
AU - Kraguljac, Nina V.
AU - McDonald, William M.
AU - Nemeroff, Charles
AU - Torous, John
AU - Alpert, Jonathan E.
AU - Rodriguez, Carolyn I.
AU - Widge, Alik S.
N1 - Publisher Copyright:
© 2021 American Psychiatric Association. All rights reserved.
PY - 2021/8
Y1 - 2021/8
N2 - “Mr. A,” a 24-year-old man, presents for evaluation of worsening depression. He describes a history of depression since adolescence, although he notes that he suffered a troubled childhood, including emotional neglect. He believes a recent breakup and having been denied a promotion precipitated this episode. “I’m sleeping all the time, and my body feels heavy,” he adds. He also reports increased appetite, weight gain, and “urges to cut, which I have not done in years.” However, he remains social and actively involved in several hobbies. He discontinued bupropion and escitalopram in the past because of “terrible headaches and irritability.” Initially, you consider starting lamotrigine. However, your office recently implemented a clinical decision support system that recommends a trial of phenelzine. The patient’s symptoms remit entirely on the medication suggested by the system. Curious as to how the system decided on this treatment, you download several papers on its development.
AB - “Mr. A,” a 24-year-old man, presents for evaluation of worsening depression. He describes a history of depression since adolescence, although he notes that he suffered a troubled childhood, including emotional neglect. He believes a recent breakup and having been denied a promotion precipitated this episode. “I’m sleeping all the time, and my body feels heavy,” he adds. He also reports increased appetite, weight gain, and “urges to cut, which I have not done in years.” However, he remains social and actively involved in several hobbies. He discontinued bupropion and escitalopram in the past because of “terrible headaches and irritability.” Initially, you consider starting lamotrigine. However, your office recently implemented a clinical decision support system that recommends a trial of phenelzine. The patient’s symptoms remit entirely on the medication suggested by the system. Curious as to how the system decided on this treatment, you download several papers on its development.
UR - http://www.scopus.com/inward/record.url?scp=85114197652&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85114197652&partnerID=8YFLogxK
U2 - 10.1176/appi.ajp.2020.20030250
DO - 10.1176/appi.ajp.2020.20030250
M3 - Review article
C2 - 34080891
AN - SCOPUS:85114197652
SN - 0002-953X
VL - 178
SP - 715
EP - 729
JO - American Journal of Psychiatry
JF - American Journal of Psychiatry
IS - 8
ER -